Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
14.43
+0.38 (2.70%)
At close: Mar 9, 2026, 4:00 PM EDT
14.43
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:02 PM EDT
Jade Biosciences Market Cap
Jade Biosciences has a market cap or net worth of $709.66 million as of March 9, 2026.
Market Cap
709.66M
Enterprise Value
374.23M
1-Year Change
n/a
Ranking
Category
Stock Price
$14.43
Market Cap Chart
Since April 29, 2025, Jade Biosciences's market cap has increased from $326.87M to $709.66M, an increase of 117.11%. That is a compound annual growth rate of 148.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 692.89M | -2.39% |
| Dec 31, 2025 | 709.84M | 117.16% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 738.16M |
| Lexicon Pharmaceuticals | 730.31M |
| Prime Medicine | 710.09M |
| Gyre Therapeutics | 700.76M |
| ProKidney | 691.92M |
| Theravance Biopharma | 687.62M |
| Tectonic Therapeutic | 673.52M |
| MiMedx Group | 668.55M |